|
|
Cancer Therapy
Links to news articles on
Cancer Therapy
.
Data advance knowledge in cancer therapy research -- 30 Mar 2006
2006 MAR 30 - (NewsRx.com) -- Cancer therapy data are the focus of recent research from the United States and India. Study 1: Recent ... Therapeutics Daily (subscription) (press release),
CytImmune Sciences Receives Phase I SBIR Grant for Next-Generation ... -- 30 Mar 2006
..."This Phase I grant will make it possible for CytImmune to develop a true multifunctional cancer therapy, providing funding for its preclinical evaluations and ... PharmaLive.com (press release),
David Parkinson, MD Joins Biogen Idec as Head of Oncology Research ... -- 30 Mar 2006
Dr. Parkinson worked for the National Cancer Institute from 1990 to 1997, rising to Acting Associate Director for the Cancer Therapy Evaluation Program. ... Genetic Engineering News,
Infinity Announces Three Leadership Promotions -- 30 Mar 2006
...of successfully discovering and developing several first-in-class agents including, most recently, Velcade®, a proteasome inhibitor for cancer therapy and ... Yahoo! News (press release)
Nexavar Approved in Switzerland for the Treatment of Patients with ... -- 30 Mar 2006
...- First European Approval in New Class of Cancer Therapy - WEST HAVEN, Conn. and EMERYVILLE, Calif., March 30 /PRNewswire-FirstCall ... PR Newswire (press release),
iSoft develops health care solution system -- 30 Mar 2006
...around eight to nine percent of its revenue for the advanced development of this product that would in future deal complex medication in cancer therapy or any ... News Today,
Doctors Test New Kind Of Cancer Therapy -- Mar 29, 2006
Liz Bonis -- Doctors are now testing a potential cancer-killing pill on patients. ... After the operation, surgeons told Jesse she had gallbladder cancer. ... 13WHAM-TV,
Health Canada approves Xeloda(R) for adjuvant therapy in the ... -- Mar 28, 2006
...setting, but can conveniently be taken at home." Health Canada's decision was based on the landmark X-ACT (XELODA in Adjuvant Colon Cancer Therapy) trial. ... Canada NewsWire (press release),
'Smart Bomb' Anti-Cancer Therapy Shows Promise -- Mar 23, 2006
Still, the treatment has the potential to be an "exciting advance," said Clodagh O'Shea, a cancer research specialist at the University of California, San ... Forbes
Cancer therapy sets treatment to body clock -- Mar 29, 2006
By Julie Deardorff. The clock was ticking for Frank Fazio. By the time his colon cancer was discovered, the disease had spread to his abdomen, spine and bones. ... Times Herald-Record,
Imaging Technology Identifies Best Responders to Cancer Therapy -- Mar 22, 2006
The results, from a study of 64 patients with esophageal cancer, are published in the April issue of Annals of Surgery. PET, a technology ... DG News
PET image predicts cancer therapy response -- Mar 22, 2006
WINSTON-SALEM, NC, March 22 (UPI) -- Positron emission tomography (PET) imaging may one day help more cancer patients avoid surgery, researchers said Wednesday ... United Press International
CANCER THERAPY TO TAKE NEXT STEP -- Mar 23, 2006
Mar. 23, 2006 - An experimental treatment that couples directed radio waves with carbon nanoparticles has proved powerful enough to kill cancer cells. ... Small Times
AmpliMed Begins Enrollment of Phase I Trial of Amplimexon in ... -- Mar 28, 2006
...cell counts), multi-drug resistance (treatment-induced resistance to many cancer drugs) and cardiac toxicity, frequently associated with current cancer therapy ... Genetic Engineering News,
Quest Diagnostics Launches the First Tests to Help Doctors Assess ... -- Mar 28, 2006
Invasive Than Bone Marrow Biopsies, Providing Doctors With New Tools to More Frequently Assess Disease Progress and Help the Physician Tailor Cancer Therapy to ... PR Newswire (press release),
COMUNICADO: 90% of Cancer Patients Completely Unaware of New ... -- Mar 27, 2006
Nine out of ten patients battling cancer in Europe have never heard of a major breakthrough in cancer treatment, known as anti-angiogenesis, according to a new ... Europa Press,
National Cancer Institute Honors Dr. Marguerite Raaen With A ... -- Mar 29, 2006
Gavin Brennan, Wei Lu, and Craig Fee of TerpSys; Beverly Meadows from the Division of Cancer Prevention and George Redmond from the Cancer Therapy Evaluation ... PR Web (press release),
Diatos Announces Expansion of Medarex Cancer Product Licensing ... -- Mar 28, 2006
...company, announced today that Medarex has granted full European commercialization rights for DTS-201 (a doxorubicin prodrug for targeted cancer therapy) to ... PR Newswire (press release),
(PRN) - MDS Nordion Offers Advanced Cancer Therapy Systems in ... -- Mar 22, 2006
...(PRN) - How Much Do We Hate Preparing Taxes? Most Would Rather Clean the House, Visit In-Laws ... [+. PRN) - Depuy Orthopaedics ... Bolsamania.com,
Hartford supports fly-fishing as cancer therapy -- Mar 20, 2006
...in Connecticut has announced its sponsorship of the Casting for Recovery program, which promotes fly-fishing as cancer therapy. ... InvestmentNews,
Colorectal Cancer Therapy Shows Promise -- Mar 14, 2006
FORT WORTH, Texas -- Chemotherapy was once the only way to treat colon cancer, but advances in drug therapies have come a long way in recent years. ... NBC5i.com,
New Data Show Zometa Increased Bone Mineral Density in Breast ... -- Mar 22, 2006
...trial in the US, Z-FAST, are part of a large, ongoing clinical trials program to investigate the treatment of bone loss in patients on cancer therapy and ... PharmaLive.com (press release),
Wasabi's Kick Linked To Single Pain Receptor -- Mar 27, 2006
..."We can now begin to consider the idea that, by blocking TRPA1 action, it might be possible to prolong cancer therapy in such cases," Julius said. ... Medical News Today (press release),
MDS Nordion Offers Advanced Cancer Therapy Systems in Europe -- Mar 22, 2006
OTTAWA, Canada, March 22 /PRNewswire/ -- The MDS Nordion Equinox, a state-of-the-art cancer therapy system, and Avanza, a patient positioning treatment table ... PR Newswire UK (press release),
New Clinical Data Show Benefits of Femara(R) for Women With Breast ... -- Mar 23, 2006
...and based at Queen's University in Kingston, Ontario, Canada, develops, conducts and analyzes national and international trials of cancer therapy, including ... PR Newswire (press release),
COMUNICADO: 90% of Cancer Patients Completely Unaware of New ... -- Mar 27, 2006
Roche and Genentech are pursuing a comprehensive clinical programme investigating the use of Avastin in advanced colorectal cancer with other chemotherapies ... Europa Press,
Pumping Iron Raises Quality of Life After Breast Cancer Surgery -- Mar 27, 2006
...of life for breast cancer survivors, but whether weight training would offer a similar benefit in women who have recently undergone breast cancer therapy was ... MedPage Today,
MDS Nordion Offers Advanced Cancer Therapy Systems in Europe -- Mar 22, 2006
Ottawa, Canada (ots/PRNewswire) - The MDS (Nachrichten) Nordion Equinox, a state-of-the-art cancer therapy system, and Avanza, a patient positioning treatment ... FinanzNachrichten.de,
The Thinkers: Celebrity deaths shine light on lung cancer -- Mar 26, 2006
...factor. Her professional goal: to bring to fruition at least one new cancer therapy, from the lab through animal studies to people. ... Pittsburgh Post Gazette,
Anti-cancer drug development collaboration -- Mar 28, 2006
Importantly, the outcomes of this research will both support the development of this promising new cancer therapy and advance cancer research UK-funded ... Laboratory Talk,
More Routine Monitoring of Bone Density, Preventive Management ... -- Mar 23, 2006
NICE, FRANCE -- March 23, 2006 -- A wide range of breast cancer patients are at risk of fracture related to bone loss, and physicians who treat them need to ... DG News
Hamilton set to undergo cancer therapy -- Mar 18, 2006
HAMPTON, Ga. (AP) -- Former NASCAR trucks champion Bobby Hamilton has a cancerous growth in his neck and will miss most, if not ... South Bend Tribune,
CUSTOMS FAILED 'DIRTY BOMB' TEST -- Mar 29, 2006
...the Government Accountability Office, Congress's audit arm, carried small amounts of cesium-137 - a radioactive material used for cancer therapy, industrial ... Free Market News Network,
Paclitaxel-Bevacizumab Combination Prolongs Progression-Free ... -- Mar 23, 2006
Using the Functional Assessment of Cancer Therapy (FACT) General (FACT-G) and Breast (FACT-B) scales, the researchers determined that bevacizumab had a neutral ... DG News
(PRN) - Volvo Names Second Annual Alexandra Scott Butterfly Award ... -- Mar 27, 2006
...(PRN) - 90% of Cancer Patients Completely Unaware of New Breakthrough Cancer Therapy Which Medical Experts Believe Could Reduce Cancer to a Chronic Disease ... ... Bolsamania.com,
90% of Cancer Patients Completely Unaware of New Breakthrough ... -- Mar 27, 2006
...- Knowledge Gap of Concern to Both Physicians and Patient Groups ZURICH, March 27 /CNW/ - Nine out of ten patients battling cancer in Europe have never heard ... CNW Telbec (Communiqués de presse),
90% of Cancer Patients Completely Unaware of New Breakthrough ... -- Mar 27, 2006
Knowledge Gap of Concern to Both Physicians and Patient Groups ZURICH, Switzerland, March 27 /PRNewswire/ -- Nine out of ten patients battling cancer in Europe ... PR Newswire Brasil (liberação de imprensa),
Breast cancer drug lifeline -- Mar 22, 2006
...patients. She added: “This is a new cancer therapy that could be applied to women who are not candidates for Herceptin. “The ... The Sun,
PDT kills drug-resistant bacteria -- Mar 23, 2006
This may be vital for patients undergoing cancer therapy, HIV patients who demonstrate resistance to antibiotics and the elderly with persistent oral infections ... University at Buffalo Reporter,
Thalidomide cancer therapy called into question -- Mar 8, 2006
Thalidomide, a drug that caused ghastly birth defects a generation ago but has been resurrected in recent years as a promising cancer treatment, failed in a ... Globe and Mail,
Prostate cancer therapy trumps wait -- Feb 28, 2006
There also has been a fear of overtreatment, as well as concerns whether the rigor of cancer therapy would be difficult in a population facing other health ... Newsday,
Optimata's Virtual Patient Technology to Support Development of ... -- Mar 27, 2006
The company is currently completing a bio-simulation clinical trial on individualized breast cancer therapy in collaboration with Nottingham City Hospital in ... Genetic Engineering News,
90% of Cancer Patients Completely Unaware of New Breakthrough ... -- Mar 27, 2006
Zurich, Suisse (ots/PRNewswire) - - Knowledge Gap of Concern to Both Physicians and Patient Groups Nine out of ten patients battling cancer in Europe have ... news aktuell (Pressemitteilung),
90% of Cancer Patients Completely Unaware of New Breakthrough ... -- Mar 27, 2006
Nine out of ten patients battling cancer in Europe have never heard of a major breakthrough in cancer treatment, known as anti angiogenesis, according to a new ... Antara,
Adjuvant therapy: Extra treatment to keep cancer from returning -- Mar 13, 2006
The newest form of anti-cancer therapy is called targeted therapy because these treatments tend to target specific abnormalities present within cancer cells ... MayoClinic.com
Unique breast cancer therapy treats 100th patient at clinic -- Mar 10, 2006
By Andrea Lavigne. For Katie Crofts, the 100th person to undergo treatment for cancer using a new technique, balloons didn't drop out of the ceiling. ... Saanich News,
Latest In Prostate Cancer Therapy Presented At A New Style ... -- Mar 9, 2006
The use of medicine is now a fundamental aspect of cancer therapy and, consequently, cancer patients need to be treated by qualified medical oncologists. ... Medical News Today (press release),
Mayor begins cancer therapy -- Mar 10, 2006
Lawrenceville Mayor Bobby Sikes, a veteran of tough elections, is now in a struggle for his life. He has been diagnosed with leukemia. ... Atlanta Journal Constitution (subscription),
Simultaneous HIV therapy and chemotherapy for lymphoma effective ... -- Feb 28, 2006
...concerns that it might interact with anti-cancer drugs mean that physicians either delay initiating antiretroviral treatment until anti-cancer therapy has been ... Aidsmap,
BSD Medical Applies for FDA Approval of the BSD-2000 Cancer ... -- Mar 24, 2006
Frost and Sullivan presented to BSD the Technology Innovation of the Year Award for cancer therapy devices based on the contribution of the BSD-2000 in the ... Market Wire (press release)
'Healthline' educates listeners about cancer -- Mar 24, 2006
..."It's a mixture of both very up-to-the-minute and state-of-the-art information about cancer therapy but also with a more personal slant as well," Miller said. ... Yale Daily News,
New drug fights breast cancer better -- Mar 23, 2006
...“This is a new cancer therapy that could be applied to women who are not candidates for Herceptin,� said Dr Robin Zon, of South Bend, Indiana, the lead ... What is the Word,
Taxotere OK'd for advanced stomach cancer -- Mar 23, 2006
Sanofi said the FDA clearance marks the first in more than 10 years of an advanced stomach-cancer therapy that has been shown to improve survival. ... United Press International
(PRN) Phase I/II Clinical Data Demonstrate Safety and Antitumor ... -- Mar 16, 2006
ADVEXIN is an investigational cancer therapy that utilizes an adenoviral vector to deliver the p53 tumor suppressor directly to tumors. ... Houston Chronicle,
Open minds are crucial in the debate on stem cell research -- Mar 23, 2006
...stem cells to regenerate bone marrow, either for patients with bone marrow disease, or for cancer patients whose marrow has been destroyed by cancer therapy. ... Sydney Morning Herald,
Dynavax to Acquire Rhein Biotech GmbH From Crucell -- Mar 27, 2006
...trial in ragweed allergic children; HEPLISAV(TM), a hepatitis B vaccine that is currently in a pivotal Phase 3 clinical trial; a cancer therapy currently in a ... Yahoo! News (press release)
Phase 1/2 Clinical Data Demonstrate Safety and Antitumor Activity ... -- Mar 16, 2006
Advexin is an investigational cancer therapy that utilizes an adenoviral vector to deliver the p53 tumor suppressor directly to tumors. ... DG News
Sarasota company's laser spectrometers help researchers -- Mar 27, 2006
Gusev said. This esoteric knowledge has become critical in fields as diverse as high-speed data transfer and cancer therapy. At ... Gainesville Sun,
Latest In Prostate Cancer Therapy Presented At A New Style ... -- Mar 10, 2006
The latest advances in prostate cancer diagnosis and treatment will be presented by experts from around the world this month at a revolutionary new meeting ... Medical News Today (press release),
Can Texas Plants Help Fight Cancer? -- Mar 22, 2006
...team’s hope that any new findings from this project will be added to the preclinical development collaborations she has ongoing with the Cancer Therapy and ... Newswise (press release)
Analysis: Aricept shows cancer benefit -- Mar 17, 2006
..."The implications of these findings are that we may already have suitable medication to treat some of the most troublesome aftereffects of cancer therapy that ... United Press International
Cataracts Common after Hematopoietic Stem Cell Transplantation ... -- Mar 14, 2006
Risk of several other health problems was also increased, but to a lesser extent. High-dose cancer therapy kills more cancer cells than moderate doses. ... Cancer Consultants (press release),
Shyness, Social Anxiety, and Impaired Self-esteem in Turner ... -- Mar 21, 2006
To confirm these findings, it is important to study other groups, such as young women with ovarian failure secondary to cancer or cancer therapy. ... Journal of American Medical Association (subscription),
Analysis: Oncophage comes up short -- Mar 24, 2006
The companies in this field are chasing a significant market for a successful cancer vaccine, Monane said. "The cancer therapy market right now is $20 billion ... United Press International
International Award Honors Discoveries In Cellular And Molecular ... -- Mar 23, 2006
...factors, a family of transcription factors that are involved in programmed cell death and tumor suppression, and have important implications for cancer therapy ... Medical News Today (press release),
GenVec Reports Fourth Quarter and 2005 Year End Financial Results -- Mar 15, 2006
...of Japan to identify a targeted cancer therapy to treat not only the primary tumor but also cancer that has metastasized to distant sites in the body ($1.6 ... Genetic Engineering News,
Early, Unproven Findings Changing Doctors' Practice -- Mar 14, 2006
In fact, use of Taxol and other taxanes as adjuvant breast-cancer therapy rose from a rate of just over 5 percent of patients before the ASCO presentation, to ... Forbes
Pepper component is focus of cancer study -- Mar 21, 2006
...gave to the mice.". The researcher thinks capsaicin could someday gain a place in adjuvant prostate cancer therapy. For example, it ... Detroit Free Press,
Majority of Women with Early-Stage Breast Cancer Receive Adjuvant ... -- Mar 13, 2006
...conclude that trends in the use of chemotherapy and hormonal therapy suggest that physicians have responded to recommendations about breast cancer therapy. ... Cancer Consultants (press release),
African American Women Bearing Unequal Burden of Colorectal Cancer -- Mar 16, 2006
The field of colorectal cancer therapy continues to advance, and chemotherapy drugs, including oral chemotherapy, have been effective in eradicating and ... EndoNurse,
Laureate Pharma and Bradmer Pharmaceuticals Announce Their ... -- Mar 16, 2006
..."Our relationship with the management of Bradmer and its potential new cancer therapy Neuradiab meets our strategic objective of working with innovative ... PR Newswire (press release),
ARIUS Research Licenses Antibody to Genentech -- Mar 22, 2006
...is a biotechnology company dedicated to personalizing cancer therapy through the discovery and development of novel anticancer monoclonal antibodies (MAbs). ... CNW Telbec (Communiqués de presse),
97th Annual AACR Meeting, Washington, DC, USA -- Mar 24, 2006
The Opening Plenary Session is titled "Looking into the Future of Cancer Therapy" and features presentations from world-renown experts such as Dr. Bert ... HTScreening (press release),
Wyeth Pharmaceuticals Announces Termination of Phase 3 Clinical ... -- Mar 16, 2006
...program of Wyeth's investigational drug temsirolimus oral tablets in combination with letrozole (Femara(R)), a currently approved breast cancer therapy, for ... Finanzen.net,
San Antonio Express-News briefcase column -- Mar 15, 2006
...(San Antonio Express-News (KRT) Via Thomson Dialog NewsEdge) Mar. 15--The Cancer Therapy & Research Center named Joseph F. Teague Jr. ... TMCnet
Survival Factor Protects Against Heart Failure -- Mar 19, 2006
Cancer researchers aim to use this innate programme for cancer therapy, artificially activating apoptosis in cancer cells which have lost this function and ... Medical News Today (press release),
Bayer Makes Move To Buy Schering AG -- Mar 25, 2006
...top-selling Betaseron® for the treatment of multiple sclerosis and Leukine®, used to boost a patient's immune system during cancer therapy, together with ... Medical News Today (press release),
Wyeth halts phase III trial of anticancer agent -- Mar 20, 2006
...cancer. The trial was evaluating temsirolimus in combination with Femara, Novartis' currently approved breast cancer therapy. The ... Pharmaceutical Business Review
Wyeth Pharma Discontinues Phase 3 Trial Of Temsirolimus Oral ... -- Mar 16, 2006
Temsirolimus is currently approved for breast cancer therapy in postmenopausal women with hormone-receptor positive metastatic breast cancer. ... Trading Markets,
New Therapies Target Cancer -- Mar 7, 2006
..."Gleevec was the first targeted cancer therapy developed based on knowledge that came from understanding the genetic basis of the disease," says Armstrong. ... Drug Discovery & Development (subscription),
(PRN) Recent FDA Action Validates ADVEXIN(R) Registration Strategy ... -- Mar 3, 2006
...neck cancer. ADVEXIN(R) is Introgen's p53 based anti-cancer therapy for which registration activities are underway. Clinical investigators ... Houston Chronicle,
MIMA Treats Metastatic Cancer Using Ultra-Precise Image-Guided ... -- Mar 14, 2006
Varian Medical Systems, Inc., of Palo Alto, California is the world's leading manufacturer of integrated cancer therapy systems, which are treating thousands ... Medical News Today (press release),
British body rejects EPO drugs for cancer patients -- Mar 17, 2006
...medicines watchdog ruled on Friday that costly erythropoietin (EPO) drugs should not be used to treat anaemia caused by anti-cancer therapy, dealing a blow to ... Reuters
Wyeth Terminates Phase 3 Clinical Program With Oral Temsirolimus ... -- Mar 16, 2006
3 clinical trial program of its investigational drug temsirolimus oral tablets in combination with letrozole, a currently approved breast cancer therapy, for ... Trading Markets,
Life sciences get a boost -- Mar 21, 2006
...detection. Applied Computational Technologies LLC, developing software to help improve radiation treatment planning for cancer therapy. ... Pittsburgh Tribune-Review,
The Healing Arts: Visual Insights Into Cancer Experience; Patient ... -- Mar 3, 2006
...will learn about the human cancer experience and how herbal and dietary supplements can be researched and used safely and effectively during cancer therapy. ... AScribe
Vanderbilt-Ingram Cancer Center Researchers Find Ginseng May ... -- Mar 15, 2006
All patients who used ginseng had received at least one type of conventional cancer therapy (eg, surgery, chemotherapy and/or radiotherapy). ... AScribe
Study: Ginseng aids cancer survival -- Mar 15, 2006
Shanghai Breast Cancer Study, which has followed 1,455 patients since 1996, and focused on women who received at least one type of conventional cancer therapy. ... United Press International
Cancer Treatments -- Feb 28, 2006
This particular study is important, he adds, because it could lead to a breast cancer therapy that only targets the mutated cells and saves the healthy ones. ... Georgetown University News, Calendars & Events,
Schering Accepts Bayer's EUR 16.3 Bln Cash Takeover Offer, To Form ... -- Mar 23, 2006
Schering's top-selling Betaseron for the treatment of multiple sclerosis and Leukine, used to boost a patient's immune system during cancer therapy, together ... Trading Markets,
Yellow Miracle -- Mar 22, 2006
...for medical purposes. A multi-arm study for its use in cancer therapy is also underway,’’ says Dr Padmanabhan. Malaria infects ... Lucknow Newsline,
Redlands firm ready to start cancer trials -- 25 Jan 2006
REDLANDS Biomedical technology firm Genelux Corp. is close to starting human trials of its cancer therapy drug in Germany. Trials ... Redlands Daily Facts,
Optimata Granted Patent for Use of Virtual Patient Technology in ... -- 25 Jan 2006
Optimata is currently completing a clinical trial to predict breast cancer therapy outcomes for cancer drugs such as Adriamycin, Docetaxel, Paclitaxel ... Genetic Engineering News,
Companion Treatment for BSD Medical's System Becomes 'Gold ... -- 25 Jan 2006
BSD Medical produces cancer therapy systems that deliver precision-focused RF/microwave energy into tumors, raising them to therapeutic temperatures. ... Market Wire (press release)
Varian Medical Systems Reports Strong Growth in Net Earnings ... -- 25 Jan 2006
...of Palo Alto, California is the world's leading manufacturer of integrated cancer therapy systems, which are used to treat thousands of patients per day. ... PR Newswire (press release),
Cancer research runs in Rauscher's blood -- 25 Jan 2006
He realized immediately that he wanted to find a way to target cancer therapy to determine which treatments would really work in individual patients. ... CNN
Kosan Initiates Phase I Clinical Trial of Oral Hsp90 Inhibitor KOS ... -- 25 Jan 2006
...sponsored by the National Cancer Institute (NCI) under a Cooperative Research and Development Agreement between Kosan and the NCI Cancer Therapy Evaluation ... Yahoo! News (press release)
Halfway house part of De Mott sentence -- 25 Jan 2006
The judge didn't mention Stephen De Mott's illness, but the priest said family members spoke to McAvoy earlier about Stephen De Mott's need for cancer therapy. ... Press & Sun-Bulletin,
Drug candidate ‘could boost lycopene effect in foods’ -- 25 Jan 2006
The potential market for GTP-0805 as a cancer therapy product is believed to be significant with global sales of current breast cancer treatments estimated to ... NutraIngredients.com,
(PRN) - MKS Instruments Announces Fourth Quarter 2005 Conference ... -- 25 Jan 2006
Dividend on all Shares ... [+. PRN) - Companion Treatment for BSD Medical's System Becomes 'Gold Standard' in Cancer Therapy ... [+. Bolsamania.com,
(PRN) - McCormick Reports Increase in 2005 Sales and Profits ... -- 25 Jan 2006
...all Shares ... [+. PRN) - Companion Treatment for BSD Medical's System Becomes 'Gold Standard' in Cancer Therapy ... [+. PRN) - MicroStrategy ... Bolsamania.com,
Dynavax to Participate in Webcast Hosted by Pacific Growth ... -- 25 Jan 2006
...trial in ragweed-allergic children; HEPLISAV(TM), a hepatitis B vaccine that is currently in a pivotal Phase 3 clinical trial; a cancer therapy currently in a ... PR Newswire (press release),
Publication Alert from Introgen Therapeutics, Inc. -- Jan 24, 2006
24, 2006 – Introgen Therapeutics, Inc.’s (NASDAQ:INGN) ADVEXIN p53 cancer therapy is the subject of a review article entitled “Adenovirus p53 Gene Therapy ... PharmaLive.com (press release),
Novel Strategies for Treating Lung Cancer: Chemotherapy -- Jan 24, 2006
Program and abstracts of the Chemotherapy Foundation Symposium XXIII: Innovative Cancer Therapy for Tomorrow; November 2-5, 2005; New York, NY. ... Medscape (subscription)
Delcath Systems Co-Sponsors First International Symposium On ... -- Jan 24, 2006
This presentation was made to surgical oncologists who are at the forefront of regional cancer therapy, some of whom are candidates for participating in the ... PR Newswire (press release),
Star quits show for cancer therapy -- Jan 20, 2006
...the US production of The Woman in White, will be out of the Andrew Lloyd Webber musical for six weeks to complete treatment for breast cancer, producers have ... Scotsman,
New gene-mapping to boost cancer therapy -- Jan 19, 2006
...have broken new ground with their work on the key tumour suppressor gene ‘p53’, raising hopes of better detection and treatment of cancer, a published ... Economic Times,
Chemo that's easier to take -- Jan 22, 2006
...chances of a cure. The recent advance in ovarian cancer therapy highlights the paradox of today's treatments. Earlier this month ... Los Angeles Times,
The health benefits of aged garlic extract -- Jan 10, 2006
...disease and have antiaging effects in improving memory, endurance and learning; 1,2 new data also show that AGE has potential as an adjuvant in cancer therapy. ... The South African Journal of Natural Medicine (subscription),
Indian healthcare model to foster global cancer mission -- Jan 23, 2006
...closely monitoring the Indian healthcare model to pick up vital clues for successful implementation of its global Programme of Action for Cancer Therapy (PACT ... Hindustan Times,
Dynavax's Ragweed Allergy Therapy, TOLAMBA(TM), Achieves Primary ... -- Jan 18, 2006
...clinical trial in ragweed-allergic children; HEPLISAV, a hepatitis B vaccine that is currently in a pivotal Phase 3 clinical trial; a cancer therapy currently ... PR Newswire (press release),
Award-winning chemistry professor joins MU faculty -- Jan 23, 2006
...a co-winner of the prestigious King Faisal International Prize for Science “for achievements that will have a profound effect on cancer therapy,� according ... Columbia Missourian,
Breast cancer therapy studied -- Jan 10, 2006
WASHINGTON - Radiation may get a little easier for thousands of breast cancer patients: Doctors now can target cancer-killing beams just at the tumor site ... Akron Beacon Journal,
UCLA Researchers Uncover Mechanism Underlying Response to Targeted ... -- Jan 11, 2006
Typically, scientists seeking a target for a new cancer therapy start work in cell lines and then advance to laboratory animals to test their theories. ... AScribe
Curis shares plunge on study results -- Jan 24, 2006
...dropped to a 52-week low Tuesday after the drug developer said its experimental cancer therapy performed worse than expected in an early study and suspended ... BusinessWeek
Nuvelo Receives FDA Fast Track Status for Alfimeprase -- Jan 23, 2006
...dedicated to improving the lives of patients through the discovery, development and commercialization of novel drugs for acute cardiovascular and cancer therapy ... Yahoo! News (press release)
Aspirin Effective in Women for Stroke, Men for Heart Attack -- Jan 18, 2006
9 issue of the Journal of Biological Chemistry, University of Pittsburgh researchers report that aspirin, combined with a promising new cancer therapy known as ... SeniorJournal.com,
Breast cancer therapy targets radiation -- Jan 10, 2006
WASHINGTON — Radiation might get a little easier for thousands of breast cancer patients: Doctors now can target cancer-killing beams at the tumor site ... The State,
AstraZeneca Picks Up 2nd Array Compound -- Jan 24, 2006
The two pharmaceutical companies agreed in 2003 to develop the first compound, a potential cancer therapy called ARRY-142886, and to collaborate on developing ... MSN Money
National Cancer Institute gives $9 million to Keck researchers -- Jan 18, 2006
...said. "This study is really intended to get at the fundamental issue of what options we have in (cancer) therapy," she added. The ... Daily Trojan Online,
Philip S. Schein, MD, FRCP joins OncoMethylome Sciences Board of ... -- Jan 23, 2006
...than currently available tests; (2) determine the aggressiveness profile of a patient’s cancer; and (3) predict and monitor response to cancer therapy for ... Carolina Newswire (press release),
NEW AMERICA -- Jan 17, 2006
Varian Medical Systems. (VAR). Varian's cancer therapy systems are used to treat thousands of patients a day. The company dominates ... Investor's Business Daily (subscription)
New Drug Lets Thyroid Cancer Patients Avoid Nasty Side Effects ... -- Jan 10, 2006
New Technique For Thyroid Cancer Therapy Eliminates Many Side Effects (September 20, 2004) -- A new technique allows patients to maintain their normal course ... Science Daily (press release)
Ovarian cancer therapy boosts survival -- Jan 5, 2006
THE prestigious US National Cancer Institute has backed research showing that a 40-year-old method of treating deadly ovarian cancer increases survival by more ... Australian,
New ovarian cancer therapy 'promising' -- Jan 5, 2006
A finding that a variation in treatment greatly increases the survival rates of women with advanced ovarian cancer has been called a great step forward by ... ABC Online,
CNY oncologist offers new ovarian cancer therapy -- Jan 8, 2006
Cancer research is incremental and usually isn't able to proclaim "significant survival benefits" for patients, but last week researchers reported a way to ... Syracuse Post Standard,
Cancer therapy doesn't deter pupil -- Dec 29, 2005
She has had cancer of the leg since she was an infant and it has spread to her eyes, which resulted in her losing her sight in one eye and which has affected ... The Mercury (subscription),
Gift to hospital honors man's wife, daughter -- Jan 23, 2006
Hospital Center plans to renovate and expand its surgery rooms, inpatient rooms, intensive care unit, orthopedic center, and infusion and cancer therapy center ... Baltimore Sun,
A cancer therapy breakthrough -- Jan 5, 2006
Pumping heavy doses of chemotherapy drugs right into the abdomen boosted survival of women with advanced ovarian cancer by 16 months in what experts call the ... Bryan College Station Eagle,
Pinoy inventor invents cancer preventive substance -- Jan 19, 2006
Among Lunasin's applications include cancer therapy with delivery system that targets cancer cells, sun protectant, skin cancer prevention and nutraceutical in ... Manila Bulletin,
'The Gray Sheet' Reviews BSD Medical's Clinical Progress and ... -- Jan 13, 2006
BSM) announced that the company has been featured in "The Gray Sheet" this week in an article entitled, "BSD Medical to File PMA for Cancer Therapy; Prepares ... PR Newswire (press release),
Genzyme Reports 22 Percent Increase in Fourth-Quarter Revenue -- Jan 10, 2006
Thyrogen is an important adjunct to thyroid cancer therapy designed to aid earlier detection of disease recurrence, and the product is additionally indicated ... Oxfordshire Bioscience Network (press release),
Chlorogen Secures Additional $6 Million in Venture Funding -- Jan 19, 2006
...of cellular responses. Chlorogen is actively pursuing a commercial TGF-beta candidate as a cancer therapy. In addition, Chlorogen ... Genetic Engineering News,
New Report Reveals Trends in Cancer Treatment and Emerging ... -- Jan 11, 2006
...account various new options. The value of the prostate cancer therapy market is over $2.6 billion in 2005. Hormone therapies continue ... Yahoo! News (press release)
TV anchor re-launches 'Bosom Buddies' -- Jan 15, 2006
As a cancer survivor, KSAT-TV Channel 12's Leslie Mouton is lending her smile (and muscle) to help re-launch Cancer Therapy and Research Center's (CTRC's ... San Antonio Business Journal,
Dynavax's Stock Jumps On Positive Allergy Drug Data -- Jan 19, 2006
Earlier in its pipeline, Dynavax has a cancer therapy in Phase II development and an asthma immunotherapeutic that has demonstrated preliminary safety and ... BioWorld Online (subscription),
Unusual weapon touted in ovarian cancer fight -- Jan 4, 2006
...women with advanced ovarian cancer 16 months longer than standard chemotherapy in a major clinical trial, an unusually significant benefit for a cancer therapy ... Boston Globe,
European Commission Grants Orphan Drug Status for AmpliMed's ... -- Jan 11, 2006
...cell counts), multi-drug resistance (treatment-induced resistance to many cancer drugs) and cardiac toxicity, frequently associated with current cancer therapy ... Genetic Engineering News,
Oncolytics Biotech Inc. Announces Commencement of Solicitation ... -- Jan 18, 2006
CALGARY, Jan. 18 /CNW/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that the Cancer Therapy Evaluation Program (CTEP), part ... CNW Telbec (Communiqués de presse),
ZIOPHARM Receives Notice of Allowance on Key ZIO-101 Patent -- Jan 17, 2006
...of our strategy for identifying products that are related to successfully marketed cancer agents and developing them for more effective and safer cancer therapy ... Genetic Engineering News,
Oncolytics Biotech Inc. Announces Commencement of Solicitation ... -- Jan 18, 2006
CALGARY, Canada, January 18/PRNewswire/ -- Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that the Cancer Therapy Evaluation ... Biotech Intelligence (press release),
Making Proteins To Fight Cancer -- Jan 13, 2006
...analyzing the entire multithousand genome. In cancer therapy, chimeric Kaiso protein could be created. The ordinary Kaiso protein ... innovations report,
ZIOPHARM Appoints Senior Vice President for Technical Operations -- Jan 19, 2006
...of efficacious, but highly toxic cancer therapies and identifies proprietary and related drugs to provide more effective and safer cancer therapy for patients. ... Genetic Engineering News,
Parents of Kids with Cancer Suffer Post-traumatic Stress -- Jan 13, 2006
The parents (119 mothers and 52 fathers) of 125 children undergoing cancer therapy were given questionnaires about their psychological state. ... ACS News Center,
CEL-SCI Corporation Releases Letter to Shareholders -- Jan 19, 2006
...people's lives. Our ultimate goal is to add Multikine to the first line cancer therapy to make the first treatment more successful. The ... Biotech Intelligence (press release),
NanoLogix Initiates Activities to Attain Fully Reporting Status -- Jan 18, 2006
...development, and commercialization of technologies for the production of bacteria, disease testing kits, alternative sources of fuel, cancer therapy, and ... Genetic Engineering News,
New way to fight ovarian cancer -- Jan 4, 2006
That is "one of the largest benefits ever observed" in a new gynecologic cancer therapy, Dr. Steven A. Cannistra of Harvard Medical School wrote in an ... Arizona Daily Star,
Dr Totada Shanthaveerappa: Alternative Healer or Quack? -- Jan 2, 2006
It is banned for human use by the federal government and known to have killed people who used it for weight loss or cancer therapy, said Gaylord Lopez ... INDOlink,
EntreMed starts mid-stage drug trials -- Jan 19, 2006
...said Thursday that it started a mid-stage study of its Panzem NCD drug, an experimental cancer therapy that is its lead drug candidate, in brain tumor patients ... BusinessWeek
Ultrasound Activates Nanoparticle Drug Delivery -- Jan 11, 2006
...paper that enhanced, nanoparticle-aided drug delivery using widely available ultrasound equipment could markedly improve the safety of cancer therapy while ... Nanotechwire.com,
Accentia Stock Rises on Study Results -- Jan 10, 2006
...jumped to a 52-week high on Tuesday after the tiny drug developer said study patients receiving its personalized cancer therapy lived substantially longer than ... MSN Money
Cowboy Breakfast tradition endures -- Jan 19, 2006
Crownhill Blvd. The plates are free, but a $5 donation is requested for the San Antonio Cancer Therapy & Research Center. For the ... San Antonio Express (subscription),
Kaiser shifting millions in care -- Jan 16, 2006
...and hospital opens the radiation oncology part of the center this spring, it will bring to Kaiser's South Bay members a specialized form of cancer therapy that ... MSNBC
Link found between light, breast cancer -- Jan 13, 2006
He also said that melatonin, an inexpensive and widely available hormone supplement, should be studied to see whether it holds promise as an anti-cancer therapy ... Globe and Mail,
Genes affect benefits of breast cancer drug -- Jan 12, 2006
...investigated whether common changes in the CYP2D6 gene influenced the outcomes of 223 women treated with tamoxifen as part of their breast cancer therapy. ... Reuters
Dr. Robert Siegel Named to Viral Genetics, Inc. Scientific and ... -- Jan 11, 2006
I hope to help Viral Genetics with preclinical cancer therapy research and move into human trials to accelerate this area of study, which is so urgently needed ... Market Wire (press release)
Breast Cancer During Pregnancy Doesn’t Affect Babies -- Jan 13, 2006
...that the majority of preterm births among women with breast cancer (10 of 12) were elective, probably to allow an earlier start of cancer therapy, the ... MedPage Today,
Novartis profit flat, charges pressure -- Jan 19, 2006
Sales of its Diovan and Lotrel hypertension drugs, Gleevec/Glivec anti-leukemia medication, Femara breast-cancer therapy and Zelmac/Zelnorm drugs for irritable ... MarketWatch
Novartis net flat in fourth quarter -- Jan 19, 2006
...to net sales growth, Novartis said, led by its Diovan and Lotrel hypertension drugs, Gleevec/Glivec anti-leukemia medication, Femara breast cancer therapy and ... MarketWatch
Pretreating with Aspirin can induce cancer cells previously ... -- Jan 8, 2006
...in the Journal of Biological Chemistry, researchers at the University of Pittsburgh, report that Aspirin, combined with a promising new cancer therapy known as ... Xagena.it,
Resistance to insulin could affect your chances of developing ... -- Jan 16, 2006
Dr. Youngberg says it's critical for a cancer patient to lower these elevated levels of serum insulin in order for cancer therapy to work. ... KUAM.com,
Nuvelo Provides 2006 Clinical Guidance at JPMorgan Conference -- Jan 9, 2006
...variety of cancers. The Company plans to investigate the role of rNAPc2 as a potential cancer therapy in 2006. In addition, Nuvelo ... PR Newswire (press release),
Goal three: Closing in on a cure -- Dec 27, 2005
...the direction the field is heading in and this is where the new therapies are going to come for the next, I predict, several decades at least for cancer therapy ... Pasadena Star-News,
Mayo Clinic Finds Aggressive Surgery Best Option For Advanced ... -- Jan 11, 2006
Encouraging Results Reported For New Breast Cancer Therapy (February 9, 2000) -- Mayo Clinic researchers report "encouraging" results with a new treatment for ... Science Daily (press release)
Metronomic chemotherapy plus antiangiogenesis drug has activity in ... -- Jan 7, 2006
...worth pursuing and are exploring this treatment concept further in a Phase II study, which extends these treatments into early stage breast cancer therapy.". ... Xagena.it,
Locks of love -- Jan 9, 2006
...or indirectly. Through research funds, cancer therapy has come a long way and more individuals are surviving this illness. These ... Central Peace Signal,
TRAIL mediates hepatic steatosis in viral hepatitis and following ... -- Jan 20, 2006
...a range of tumor cells while having little or no apparent effect on healthy cells, and recombinant soluble TRAIL has been considered as a cancer therapy agent. ... Nature.com (subscription),
... Go to the Article -- Jan 4, 2006
...bone loss, Hahn says. There are many causes of bone loss in addition to cancer therapy that need to be examined. Hahn is working ... CancerWise
Slowly, Cancer Genes Tender Their Secrets -- Dec 28, 2005
...would be dead. As for the future of cancer therapy, Dr. Golub and others say that Gleevec offers a taste of the possible. Dr. Golub ... Spartanburg Herald Journal (subscription),
Japanese drugmaker may expand Durham, NC, presence -- Jan 4, 2006
The company's leading cancer therapy is a breast cancer treatment that recently completed Phase II clinical trials. Eisai couldn ... TMCnet
CancerVax and Micromet Announce Merger Agreement -- Jan 9, 2006
This approach may have advantages, since in cancer therapy, patient-derived cancer tissue has to be recognized as "foreign" and eliminated by the patient's T ... Market Wire (press release)
Adherex Activates Phase I Trial of Eniluracil -- Jan 4, 2006
It has the potential to make a mainstay of contemporary cancer therapy, 5-FU, even better, and could have a market opportunity in excess of a billion dollars ... Business Wire (press release),
PDL shares slip on Genentech results -- Jan 11, 2006
PDL also receives payments on Genentech's Herceptin, a breast cancer therapy, its Xolair asthma drug and the Raptiva psoriasis treatment. ... BusinessWeek
BSD Medical Announces Distribution Agreement for Entry Into ... -- Jan 4, 2006
Hyrum A. Mead, President and CEO of BSD Medical, said, "We believe that Ktech is highly qualified to sell and support our cancer therapy systems in Japan, and ... PR Newswire (press release),
STOCKS TO WATCH E-MAIL -- Jan 9, 2006
In late December, Amgen announced a $2.2-billion deal to acquire Abgenix, with whom it has been partnering to develop a potential new cancer therapy called ... Kiplinger.com,
Frederick Community Calendar -- Jan 11, 2006
Support group for adult patients and family members affected by leukemia, Hodgkins Disease and non-Hodgkins lymphoma, 6:30-8 pm, Regional Cancer Therapy Center ... Business Gazette,
Hydrogen peroxide keeps ears clean -- Jan 3, 2006
But don't delay. As a general rule, the longer a patient waits to have cancer therapy, the less the chance for success and the fewer the treatment options. ... Monterey County Herald,
DiagnoCure expects royalties to begin this year from prostate ... -- Jan 8, 2006
The trials are to test GSK's own prostate cancer therapy. Analyst Hugues Bourgeois said the selection of PCA3 by GSK is a huge vote of confidence. ... Calgary Sun,
Cancer Researchers Describe Gene That Halts Spread Of Aggressive ... -- Jan 8, 2006
...typically the gene is simply silenced. This paper opens up a new way of thinking about cancer therapy. "Now we have a roadmap for ... Science Daily (press release)
Promising Target For Cancer Therapies Validated In New Study -- Jan 2, 2006
Temple University Researchers Develop New Targeted Cancer Therapy (April 10, 2005) -- Temple University researchers have developed a new drug that halts cancer ... Science Daily (press release)
Caution tempers hopes for biotech -- Dec 27, 2005
Dendreon cobbled together data that showed 33 percent of men treated with Provenge, its prostate-cancer therapy, were alive after three years, compared with 15 ... Seattle Times,
2005, A Cancer Year in Review -- Dec 29, 2005
Cancer Treatments - Responses, Survival & Placebo: Defining an Effective Cancer Therapy reported on how cancer therapies are labeled "effective" by oncologists ... Emediawire (press release),
Neopharm stock jumps on brain cancer study -- Dec 27, 2005
2006. Neopharm said it would then consider whether to file with the Food and Drug Administration for approval of the cancer therapy. ... United Press International
Pediatric Cancer Research Breakthrough -- Jan 5, 2006
...already metastasized. The average age at diagnosis is two years old. The research provides a new way of thinking about cancer therapy. All Headline News
MGI Sees 2006 Sales Below Wall Street View -- Jan 10, 2006
...up to $300 million for its Aloxi injection, about $40 million from its Gliadel wafer and around $25 million from its yet-to-be-approved Dacogen cancer therapy. ... MSN Money
Bioxel Pharma in Talks to Complete a $4M Private Placement -- 23 Dec 2005
The Corporation sells cGMP paclitaxel and develops a portfolio of other generic taxane APIs and taxane-based proprietary products for improved cancer therapy. ... CCNMatthews (press release),
Procyon's Shares are Now Eligible Within the Quebec SME Growth ... -- 23 Dec 2005
2005 Frost & Sullivan Award for Excellence in Technology for its overall scientific and technological contributions towards the advancement of cancer therapy. ... Biotech Intelligence (press release),
Helix BioPharma Corp. signs L-DOS47 Manufacturing Agreement with ... -- 23 Dec 2005
About Helix BioPharma Corp. Helix BioPharma Corp. is a biopharmaceutical company specializing in the field of cancer therapy. The ... CNW Telbec (Communiqués de presse),
Poly(amidoamine) dendrimer-based nanodevice developed for cancer ... -- Nov 24, 2005
2005 NOV 30 - (NewsRx.com) -- Scientists have developed a poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy. ... TMCnet
Patients still support doctor despite federal indictment -- Dec 22, 2005
It is banned for human use by the federal government and known to have killed people who used it for weight loss or cancer therapy, said Gaylord Lopez ... Macon Telegraph,
Merck KGaA Receives Approval for Erbitux in Head and Neck Cancer -- Dec 22, 2005
...today that Swissmedic, the Swiss Agency for Therapeutic Products, has granted marketing authorization to extend the use of the targeted cancer therapy, Erbitux ... PharmaLive.com (press release),
Weedkiller never OK'd for humans -- Dec 21, 2005
It's also banned for human use by the federal government and known to have killed individuals using it for weight loss or in cancer therapy, said Gaylord Lopez ... Atlanta Journal Constitution (subscription),
A new study gives credence to "targeted" cancer therapy -- Dec 16, 2005
An alternative to traditional radiation could allow some breast cancer patients to be treated in less time, according to a small study presented in Denver at ... Asbury Park Press,
Researchers study breast cancer therapy -- Dec 15, 2005
A study of more than 1,000 women compared the effectiveness of two different adjuvant chemotherapy programs used in the treatment of breast cancer. ... myDNA.com,
ViaCell to resume cancer therapy trial -- Dec 19, 2005
19 (UPI) -- ViaCell said Monday has been approved to resume its study of CB001 for hematopoietic stem-cell transplant in cancer patients. ... United Press International
Southeast Nebraska Cancer Center Receives Major Research Funding -- Dec 20, 2005
..."It looks increasingly promising that this form of genetic testing will improve development of cancer therapy and help more people survive cancer.". ... Yahoo! News (press release)
US International Trade Commission to Investigate Possible Patent ... -- Dec 21, 2005
Varian Medical Systems, Inc. is the world's leading manufacturer of integrated cancer therapy systems, which are used to treat thousands of patients per day. ... ag-IP-news Agency,
Novelix Announces In-Licensing and Development Plans for a Novel ... -- Dec 20, 2005
...(Novelix) is a biotechnology company committed to developing proprietary first-in-class targeted small molecules for cancer therapy. ... PharmaLive.com (press release),
Aspirin Helps Kill Cancer Cell Resistance To Targeted Therapy -- Dec 12, 2005
9 issue of the Journal of Biological Chemistry, University of Pittsburgh researchers report that aspirin, combined with a promising new cancer therapy known as ... Medical News Today (press release),
Winning combo: Aspirin, cancer therapy -- Dec 13, 2005
9 Journal of Biological Chemistry, University of Pittsburgh researchers report that aspirin combined with a promising new cancer therapy known as tumor ... myDNA.com,
Strides made in lung cancer therapy and survival rates -- Dec 11, 2005
I was recently asked to see a patient in consultation for stage II nonsmall-cell lung cancer. ... This is a very large reservoir of potential lung cancer victims. ... St. Petersburg Times,
Hormone May Predict Infertility After Cancer Therapy -- Dec 13, 2005
...suggest that the hormone inhibin A may be a marker of premature ovarian failure in premenopausal women being treated for breast cancer, according to a ... Cancerpage.com,
New Products and Line Extensions are the Contributing Factors to ... -- Dec 20, 2005
...account various new options. The value of the prostate cancer therapy market is over $2.6 billion in 2005. Hormone therapies continue ... Business Wire (press release),
Genentech/Roche: expanding Avastin's empire -- Dec 20, 2005
...phase III clinical performance, Genentech has submitted a supplemental biologics license application for its Roche co-marketed cancer therapy Avastin in ... Pharmaceutical Business Review
US Market for Cancer Therapy Products & Services to Exceed $27 ... -- Dec 13, 2005
CLEVELAND, OH -- (MARKET WIRE) -- 12/13/2005 -- The US market for cancer therapy products and services is projected to increase 10.0 percent per year through ... Market Wire (press release)
Tough guy coping with cancer therapy -- Dec 10, 2005
A biopsy followed. Then, the terrible news: something was terribly wrong. Prostate cancer. Radical surgery told doctors the cancer was aggressive. ... Winnipeg Free Press (subscription),
Novelix acquires rights to anticancer candidates -- Dec 21, 2005
Novelix Pharmaceuticals is a biotechnology company committed to developing first-in-class targeted small molecules for cancer therapy. ... Pharmaceutical Business Review
Bayer wins US FDA approval for Nexavar kidney cancer drug -- Dec 20, 2005
...'The FDA approval of Nexavar is a crucial step for patients with advanced kidney cancer therapy,' chief executive Werner Wenning said in a statement. ... Forbes
Woman wins right to fight for new breast cancer drug -- Dec 21, 2005
The drug, a completely new type of targeted cancer therapy, costs about £19,500 for one patient for a one-year course of treatment. ... Telegraph.co.uk,
Varian: ITC Opens Resonant Imports Probe -- Dec 20, 2005
PALO ALTO, Calif. (AP) - Varian Medical Systems Inc., a maker of cancer therapy devices, said Tuesday that the International Trade Commission has launched a ... MSN Money
Varian: ITC opens Resonant imports probe -- Dec 20, 2005
20 12:53 PM ET Varian Medical Systems Inc., a maker of cancer therapy devices, said Tuesday that the International Trade Commission has launched a probe on ... BusinessWeek
Adherex Receives FDA Orphan Drug Designation for Eniluracil in ... -- Dec 21, 2005
...inhibiting its breakdown. Although 5-FU is a mainstay of contemporary cancer therapy, it has some therapeutic drawbacks. These include ... CCNMatthews (press release),
Research suggests melatonin could soon be used in cancer therapy -- Dec 7, 2005
A new study published in the Journal of Pineal Research claims that melatonin could play a major role in future cancer therapies. ... Newstarget.com,
New method seen as promising in evaluating lung cancer treatment -- Dec 19, 2005
Although medical science has come a long way in recently years, Pai said lung cancer therapy has not seen much progress; most patients are only diagnosed with ... Taiwan Headlines,
Interim Analysis of Phase 3 Study Shows Taxotere (docetaxel)-Based ... -- Dec 16, 2005
...chemotherapy (TCH). Doxorubicin has been considered a standard agent in early breast cancer therapy for over 25 years. Women whose ... DG News
Heralded cancer drug a nimble weapon against other diseases -- Dec 18, 2005
But they are proving to be important, both for cancer therapy and for the treatment of other diseases that involve abnormal vessel formation. ... Boston Globe,
Helix BioPharma signs L-DOS47 manufacturing agreement with QSV ... -- Dec 20, 2005
More information can be obtained from www.qsvbiologics.com. Helix BioPharma Corp. is a biopharmaceutical company specializing in the field of cancer therapy. ... PharmaLive.com (press release),
Mayo Clinic Reports Tamoxifen Benefit For Breast-cancer Patients ... -- Dec 19, 2005
Encouraging Results Reported For New Breast Cancer Therapy (February 9, 2000) -- Mayo Clinic researchers report "encouraging" results with a new treatment for ... Science Daily (press release)
Two Types Of Breast Cancer Treatments Show Similar Benefit -- Dec 17, 2005
Encouraging Results Reported For New Breast Cancer Therapy (February 9, 2000) -- Mayo Clinic researchers report "encouraging" results with a new treatment for ... Science Daily (press release)
Breast cancer drug may work in lung cancer -- Dec 16, 2005
Press International she thought the study was well-constructed and supported the further evaluation of aromatase as a potential target for lung cancer therapy. ... Science Daily (press release)
(PRN) Introgen's INGN 241 Shows Promise in Treatment of Breast ... -- Dec 12, 2005
12 /PRNewswire-FirstCall/ -- Introgen Therapeutics, Inc. (Nasdaq: INGN) today reported that in preclinical studies its investigational cancer therapy INGN 241 ... Houston Chronicle,
Nano World: How nanotubes enter cells -- Dec 20, 2005
...such as hollow nanoparticles, for use in drug and gene delivery, and gold-silica nanoparticles known as nanoshells for a heat-based anti-cancer therapy similar ... United Press International
Couple donate $5M to fight cancer -- Dec 17, 2005
...the tools to diagnose at the earliest possible time point, to treat with the most appropriate therapy, and to monitor the effectiveness of cancer therapy in ... Edmonton Journal,
Distance from facility affects cancer therapy -- Nov 28, 2005
...to reach a radiation therapy facility appears to influence whether she receives the recommended treatment for early-stage breast cancer, investigators report. ... Reuters
Alzheimer's patients get less breast cancer therapy -- Nov 30, 2005
NEW YORK (Reuters Health) - Women with Alzheimer's disease receive less treatment for breast cancer than do comparable female Medicare beneficiaries, the ... Reuters.uk,
RSNA News Cover Article Focuses Attention on Hyperthermia Cancer ... -- Nov 29, 2005
...and Sullivan recognized BSD Medical's advanced cancer treatment systems with this year's "Technology Innovation of the Year Award" for cancer therapy devices. ... PR Newswire (press release),
Alzheimer‘s patients get less breast cancer therapy -- Nov 30, 2005
NEW YORK (Reuters Health) - Women with Alzheimer‘s disease Alzheimer‘s disease receive less treatment for breast cancer than do comparable female Medicare ... Brocktown News,
New clinical data show dramatic benefits of Femara* for women with ... -- Dec 13, 2005
...and based at Queen's University in Kingston, Ontario, Canada, develops, conducts and analyzes national and international trials of cancer therapy, including ... Canada NewsWire (press release),
SAFC announces ruthenium cancer therapy agreement - 29th November ... -- Nov 29, 2005
...that its pharmaceutical branch has been appointed to deliver current good manufacturing practices (cGMF) of its lead ruthenium cancer therapy compounds. ... Platinum today,
Introgen's INGN 241 Shows Promise in Treatment of Breast Cancer ... -- Dec 12, 2005
...today reported that in preclinical studies its investigational cancer therapy INGN 241 reduced tumor growth and increased tumor cell death in various breast ... PharmaLive.com (press release),
Introgen's INGN 241 Shows Promise in Treatment of Breast Cancer ... -- Dec 12, 2005
...(Nasdaq: INGN - News) today reported that in preclinical studies its investigational cancer therapy INGN 241 reduced tumor growth and increased tumor cell ... Yahoo! News (press release)
(PRN) GlaxoSmithKline Initiates Trial Of Tykerb (Lapatinib) in ... -- Dec 9, 2005
A similar population of patients was studied in a National Cancer Institute-sponsored study [Cancer Therapy Evaluation Program (CTEP) Trial 6969], and recently ... Houston Chronicle,
Herceptin Plus Chemotherapy Improves Disease-free Survival In ... -- Dec 8, 2005
...angiogenesis inhibitor Avastin. That, Slamon said, may be the future of breast cancer therapy - the elimination of chemotherapy. "In the ... Science Daily (press release)
Slashback: Cancer, Cats, ICANN -- Dec 7, 2005
But I suppose if they can patent the human genome... Or is it really the application of this virus as cancer therapy that's been patented? ... Slashdot
New evidence entered in murder case -- Dec 21, 2005
...done. Positron Emission Tomography scans the body's cells and is most often used to detect cancer and the effects of cancer therapy. ... St. Augustine Record,
Tobacco takes its toll on Indiana economy -- Dec 18, 2005
And Medicare picks up the tab for the elderly recovering from possible tobacco-related diseases such as lung cancer. "The (cancer) therapy didn't cost me much ... Muncie Star Press,
Good news from schools -- Dec 17, 2005
Providence Christian Academy raised more than $47,000 to support experimental cancer therapy in honor of a student who died after a 20-month battle against ... Gwinnett Daily Post,
Vitamin-radiation link studied -- Dec 8, 2005
The research, funded by a two-year, $236,500 grant from the National Cancer Institute, could settle a controversy between two opposing cancer-therapy camps ... University at Buffalo Reporter,
View Profiles of 165 Companies Involved in Developing Innovative ... -- Dec 15, 2005
...formulations for different routes of delivery. The focus is on targeted cancer therapy. The newer approaches to cancer treatment ... PharmaLive.com (press release),
65% Of Ovarian Cancer Cells Sideline Body's Defences, Study -- Dec 17, 2005
Michael Krainer. The work, supported by the Austrian Science Fund FWF, may be a big help in optimising a new cancer therapy candidate. ... Medical News Today (press release),
New Diagnostic Assay for Pancreatic Cancer Reported in Journal of ... -- Dec 16, 2005
MUC1 is an antigen recognized by the PAM4 antibody, which is in Phase 1 clinical trials as a radiolabeled antibody for pancreas cancer therapy. ... PR Newswire (press release),
NANOLOGIX MANAGEMENT OPPOSING HOSTILE TAKEOVER BID OF COMPANY ... -- Dec 20, 2005
...development, and commercialization of technologies for the production of bacteria, disease testing kits, alternative sources of fuel, cancer therapy, and ... Small Times
Alzheimer's patients get less breast cancer therapy -- Nov 30, 2005
Nov 30, 2005 — NEW YORK (Reuters Health) - Women with Alzheimer's disease receive less treatment for breast cancer than do comparable female Medicare ... ABC News
Experiments Show Very Weak chlorine Solutions Can Kill Noroviruses -- Dec 20, 2005
Medical Scientists To Begin Clinical Trials Of Promising Cancer Therapy (November 8, 1999) -- Scientists at the University of North Carolina at Chapel Hill are ... Science Daily (press release)
Alzheimer's Patients Get Less Breast Cancer Therapy -- Dec 1, 2005
NEW YORK NOV 30, 2005 (Reuters Health) - Women with Alzheimer's disease receive less treatment for breast cancer than do comparable female Medicare ... Cancerpage.com,
Aspirin may cripple cancer cells -- Dec 14, 2005
...in the December 9 issue of the Journal of Biological Chemistry, Pitt researchers report that aspirin, combined with a promising new cancer therapy known as ... The Advocate,
Aspirin may cripple cancer cell resistance -- Dec 12, 2005
The researchers report aspirin, combined with a promising new cancer therapy known as tumor necrosis factor-related apoptosis-inducing ligand, or TRAIL, can ... Webindia123,
Chemo, drug combo fights breast cancer -- Dec 8, 2005
...worth pursuing, and are exploring this treatment concept further in a phase 2 study, which extends these treatments into early-stage breast cancer therapy.". ... myDNA.com,
Zenotech to launch two bio generics in Feb, plans GDR -- Dec 20, 2005
HYDERABAD: Hyderabad-based Zenotech Laboratories Ltd is all set to launch in February next two generic biological products, used in cancer therapy. ... Newindpress,
Switch from Tamoxifen to Letrozole Results in Significant ... -- Dec 12, 2005
107 women who took part in an open label cross-over study were required to complete hot flush frequency diaries, Functional Assessment of Cancer Therapy (FACT ... DG News
Low-Dose Chemotherapy Plus Antiangiogenesis Slows Advanced Cancer -- Dec 8, 2005
...pursuing and says they are exploring this treatment concept further in a Phase II study, which extends these treatments into early stage breast cancer therapy. ... Ivanhoe,
Professors receive NIH research funding -- Dec 12, 2005
...project leader. “Our research project has a direct impact in the field of cancer therapy,� said Bandyopadhyay. Photodynamic ... Hendrix College Events and News,
Health and Science News Roundup -- Dec 12, 2005
The researchers report aspirin, combined with a promising new cancer therapy known as tumor necrosis factor-related apoptosis-inducing ligand, or TRAIL, can ... Monsters and Critics.com,
AstraZeneca's Casodex may get boost -- Dec 8, 2005
AstraZeneca's drug has been struggling since 2003, when an initial analysis of the EPC trial data suggested the prostate cancer therapy increased mortality. ... Science Daily (press release)
New Cancer Treatment System by BSD Medical Destined for Fourth ... -- Dec 15, 2005
BSD was the recipient of the 2005 Frost and Sullivan "Technology of the Year Award" for the development of the BSD-2000 cancer therapy system. ... PR Newswire (press release),
Human Genome Sciences Reports Results of Phase 2 Clinical Trial of ... -- Dec 12, 2005
20. Younes A, Kadin ME. Emerging applications for the tumor necrosis factor family of ligands and receptors in cancer therapy. J Clin Oncol 2003;21:3526-3534. ... Yahoo! News (press release)
Dynavax's HEPLISAV(TM) Hepatitis B Vaccine Shows Statistically ... -- Dec 19, 2005
...supportive clinical trial in ragweed allergic children; a hepatitis B vaccine that is currently in a pivotal Phase 3 clinical trial; a cancer therapy currently ... PR Newswire (press release),
Don Peasley -- Dec 17, 2005
...research. "Advances in Targeted Cancer Therapy" reflects major advances in the understanding of molecular and tumor biology. Richard ... Northwest Herald,
Frequent, Low-Dose Chemo Fights Advanced Breast Cancer -- Dec 8, 2005
...worth pursuing and are exploring this treatment concept further in a Phase II study, which extends the treatments into early stage breast cancer therapy," Dr ... Forbes
Favrille: FavId Improves Cancer Drugs -- Dec 13, 2005
Mid-stage clinical trial data showed the company's FavId treatment increased the clinical response rate to the cancer therapy Rituxan to 65 percent from 49 ... MSN Money
Experimental method delivers assault on blood cancer -- Dec 11, 2005
...in 2001, which revolutionized the treatment of chronic myeloid leukemia and marked the beginning of what scientists hope will be a new era in cancer therapy. ... USA Today
Amgen to buy Abgenix -- Dec 15, 2005
Amgen and Abgenix have been collaborating on developing two major drug candidates, most notably the cancer therapy panitumumab. ... MarketWatch
Good news, bad news in battle against breast cancer -- Dec 8, 2005
The annual symposium is sponsored by Baylor College of Medicine and the San Antonio Cancer Institute, an alliance between the Cancer Therapy and Research ... San Antonio Express (subscription),
Pharma Reformulates -- Dec 5, 2005
Novartis' similar product Lucentis. VEGF is also the target for the cancer therapy Avastin. With personalized medicines perhaps ... Chemical & Engineering News
New Cancer Treatment System by BSD Medical Acquired to Pioneer ... -- Dec 13, 2005
...the use of the BSD-2000 for treatment of these cancers is expected to further demonstrate and broaden the application of the BSD-2000 in cancer therapy. ... PR Newswire (press release),
Firm tests therapy on leukemia -- Nov 30, 2005
Seattle Genetics said Tuesday it has initiated a 60-patient clinical trial of an experimental cancer therapy for chronic lymphocytic leukemia (CLL). ... Seattle Times,
Eating for health -- Dec 5, 2005
The Gerson Therapy Handbook, companion workbook to A Cancer Therapy: Results of 50 Cases, draws out all the recipes and methods to be used by the patients. ... Malaysia Star,
Immunomedics shares rise on pending deal -- Dec 15, 2005
Piros added in a report that Amgen Inc.'s decision to buy Abgenix Inc., which is developing a targeted cancer therapy called panitumumab, "indicates that ... BusinessWeek
Bone Marrow Micrometastasis Linked with Poor Outcome in Early ... -- Dec 9, 2005
BMM predicted prognosis among women treated only with chemotherapy or hormonal therapy, as well as among women who received no systemic cancer therapy. ... Cancer Consultants (press release),
Vertex Pharmaceuticals Announces that VX-680 Demonstrates Effect ... -- Dec 7, 2005
The progress announced today affirms our view that VX-680 and Aurora kinase inhibitors have the potential to play an important role in cancer therapy.". ... PR Newswire (press release),
Lorus announces international conference presentation of the ... -- Dec 12, 2005
This study is being sponsored by the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute under a Clinical Trials Agreement (CTA) between ... PR Newswire (press release),
Nuvelo Receives Special Protocol Assessment for Phase 3 Trial of ... -- Dec 14, 2005
...dedicated to improving the lives of patients through the discovery, development and commercialization of novel drugs for acute cardiovascular and cancer therapy ... PR Newswire (press release),
SABCS: A Switch to Arimidex After Two Years of Tamoxifen Improves ... -- Dec 10, 2005
10 - Postmenopausal women taking tamoxifen as adjuvant breast cancer therapy can improve their chances of a lengthy survival by 29% if they switch to the ... MedPage Today,
Fc-gamma IV receptor allows the most efficient IgG isotypes to ... -- Dec 10, 2005
...with the highest affinity for activating the right combination of Fc gamma receptors is critical if you want to improve antibody-mediated cancer therapy, viral ... Xagena.it,
2ND UPDATE: Amgen To Buy Abgenix For $2.2 Bln -- Dec 14, 2005
Amgen and Abgenix have been collaborating on developing two major drug candidates, the cancer therapy panitumumab and denosumab, a treatment for osteoporosis ... Business Online,
US launches cancer gene mapping project -- Dec 13, 2005
...launched on Tuesday a pilot project to find all the little genetic changes that cause cancer and hope it can open a whole new world of targeted cancer therapy. ... Reuters
$100m to trace genetic cancer markers -- Dec 14, 2005
...researchers have launched a $100m project to find all the little genetic changes that cause cancer, hoping it can open a whole new world of cancer therapy. ... Melbourne Herald Sun,
Glaxo Bullish on Cancer Drugs -- Nov 30, 2005
GlaxoSmithKline said Wednesday it will have four cancer drug candidates in advanced trials by 2006 including one breast cancer therapy the drug maker believes ... Red Herring,
(PRN) The Group Room(R) Cancer Radio Talk Show Broadcasts From the ... -- Dec 8, 2005
Southern California. The San Antonio Breast Cancer Symposium (SABCS) is a division of Cancer Therapy & Research Center (CTRC). CTRC ... Houston Chronicle,
Gene mapping project promises new targeted cancer therapies -- Dec 14, 2005
...week launched a pilot project to find all the little genetic changes that cause cancer in the hope it will lead to a whole new world of targeted cancer therapy ... News-Medical.net,
Breast cancer specialists to talk therapies, tests at SA meeting -- Dec 7, 2005
Baylor. SACI is an alliance between the local Cancer Therapy & Research Center and the University of Texas Health Science Center. San Antonio Express (subscription),
New Cancer Research May Be Door-Opener -- Dec 14, 2005
...cancer. They are hoping, in its success, that it will open up a stage of targeted cancer therapy, according to published reports. ... Post Chronicle
Unaddressed psych disorders common with cancer -- 14 Nov 2005
..."In our study of advanced cancer patients undergoing cancer therapy, fewer than half of the patients with active major psychiatric complaints received care ... Reuters.uk,
Nuvelo Phase 2a Trial Results Show rNAPc2 is Well Tolerated in ... -- 14 Nov 2005
...dedicated to improving the lives of patients through the discovery, development and commercialization of novel drugs for acute cardiovascular and cancer therapy ... PR Newswire (press release),
Procyon announces third quarter 2005 results -- 14 Nov 2005
2005 Frost & Sullivan Award for Excellence in Technology for its overall scientific and technological contributions towards the advancement of cancer therapy. ... PR Newswire (press release),
The Spirit Of A Startup Lives On -- 14 Nov 2005
Sugen co-founder Axel Ullrich has even licensed back a Sugen patent from Pfizer and is using it as the basis for a new cancer therapy at another company he has ... BusinessWeek
GSW Worldwide to Lead SaforisTM Launch Campaign for MGI PHARMA ... -- 14 Nov 2005
...body. Rapid and increased absorption of glutamine becomes critical when oral mucosa has been injured from cancer therapy. Increased ... PharmaLive.com (press release),
Curis posts loss despite revenue increase -- 14 Nov 2005
...over-year drop in product-licensing fees and an $819,491 payment to San Francisco-based Genentech Inc., which has teamed with Curis to develop a cancer therapy ... Boston Business Journal,
High-performance Computers Become Interactive -- 14 Nov 2005
Jude Children's Research Hospital are using Star-P to analyze MRI examinations for quantifying the impact of cancer therapy on blood volume and flow in the ... PR Newswire (press release),
BioMS Medical announces third quarter 2005 results -- 14 Nov 2005
...to initiate a Phase I clinical trial for HYC750, a therapeutic designed to mobilize stem cells and neutrophils for the treatment of cancer therapy related side ... PharmaLive.com (press release),
Is my uterus too small? -- 14 Nov 2005
Environmental causes include pelvic surgery, cancer therapy (Chemotherapy and Radiotherapy) and viral infections of the ovary, Anorexia nervosa may also ... Jamaica Observer,
New ECCO 13 studies probe impact of haematological cancer therapy ... -- Nov 8, 2005
An average of 16 years after their cancer therapy these patients were questioned about their attempts and successes in achieving parenthood. ... Medical News Today (press release),
Texas girl now in Wichita for cancer therapy -- Nov 7, 2005
BY KATHRYN GARCIA. Texas cancer patient Katie Wernecke is in Wichita this week, where her father hopes intravenous vitamin C treatment will save her life. ... Kansas.com,
Amgen: Cancer therapy slows tumor growth -- Nov 3, 2005
...said Thursday that its experimental colon cancer therapy, a potential rival to ImClone Inc.'s Erbitux, significantly slowed tumor growth in a late-stage study. ... BusinessWeek
Cancer therapy from Endocyte clears hurdle -- Nov 3, 2005
WEST LAFAYETTE, Ind. -- Endocyte has moved one step closer to patenting its innovative cancer therapy. The US Patent and Trademark ... Indianapolis Star,
Imaging Method Shows Early in Treatment if Brain Cancer Therapy Is ... -- Nov 1, 2005
ANN ARBOR, MI -- November 1, 2005 -- A special type of MRI scan that measures the movement of water molecules through the brain can help doctors determine ... DG News
Imaging Method Shows Early in Treatment if Brain Cancer Therapy Is ... -- Oct 31, 2005
Newswise — A special type of MRI scan that measures the movement of water molecules through the brain can help doctors determine halfway through treatment ... Newswise (press release)
New face of cancer therapy -- Oct 30, 2005
By Rebecca Imperati. Although dressed in a hospital gown, when Anita Drake was singing she was no longer a patient. While waiting ... Poughkeepsie Journal,
Diffusion MRI shows early in treatment if brain cancer therapy is ... -- Nov 5, 2005
A study has shown that a special type of MRI scan that measures the movement of water molecules through the brain can help physicians determine halfway through ... Xagena.it,
Diffusion MRI Provides Fast Assessment of Brain Cancer Therapy -- Nov 1, 2005
By Jeff Minerd, MedPage Today Staff Writer. ANN ARBOR, Mich., Nov. 1 -- An experimental form of MRI may be able to spot quickly whether ... MedPage Today,
BSD Medical's Cancer Therapy Makes Hot News -- Nov 1, 2005
SALT LAKE CITY, Nov. 1 /PRNewswire-FirstCall/ -- BSD Medical Corp. today reported some of the US October news coverage that has ... PR Newswire (press release),
Women show a better response to lung cancer therapy, resulting in ... -- Nov 3, 2005
Women with lung cancer are living longer than men, even when the disease is untreated. A new study presented at CHEST 2005, the ... News-Medical.net,
Cancer therapy -- Nov 1, 2005
By MIKE SCHWARTZ / The Press-Enterprise. We've written a lot on breast cancer because so many recent breakthroughs have come out ... Press-Enterprise (subscription),
Archivas Customer Cancer Therapy and Research Center Receives ... -- Nov 3, 2005
3, 2005--Archivas(TM), Inc., a leading provider of fixed content archiving solutions, today announced that its customer, the Cancer Therapy & Research Center ... Business Wire (press release),
Breast cancer therapy cut to five days -- Oct 23, 2005
By LISA ALLISON. A GROUNDBREAKING treatment that delivers cancer-fighting radiotherapy treatment inside the breast has just been ... Advertiser Adelaide,
Mammograms, Drug Therapy Led to Plunge in Breast Cancer Deaths -- Oct 27, 2005
Others pointed to the high number of false-positive findings. Both would lead to unnecessary treatment with toxic cancer therapy. ... Bloomberg
Philips Unveils Radiation Oncology Advances to Help Improve Cancer ... -- Oct 18, 2005
ANDOVER, Mass.--(BUSINESS WIRE)--Oct. 18, 2005--Philips Medical Systems, a division of Royal Philips Electronics (NYSE: PHG, AEX ... Business Wire (press release),
Gene Profile Aids Breast Cancer Adjuvant Therapy Choice -- Oct 18, 2005
Dr. Jonas Bergh of the Karolinska Instutet, Stockholm, and colleagues note that although adjuvant breast cancer therapy significantly improves survival ... Cancerpage.com,
Yet Another Potential Cancer Therapy -- Oct 18, 2005
Barring poor luck, it seems unlikely that I will die from cancer. I may be greatly inconvenienced by cancer, financially at the very least, but not killed. ... Methuselah Foundation,
Philips unveils radiation oncology advances to help improve cancer ... -- Oct 19, 2005
.../noticias.info/ Philips Medical Systems, a division of Royal Philips Electronics(NYSE: PHG, AEX: PHI) today unveiledadvances in its portfolio of leading ... noticias.info,
Innovative cancer therapy for tomorrow -- Oct 24, 2005
...of the Department of Medicine of Mount Sinai School of Medicine and the Chemotherapy Foundation will jointly sponsor "Innovative Cancer Therapy for Tomorrow ... EurekAlert (press release),
Much to be done in cancer therapy field -- Oct 26, 2005
The recent headlines on the First Lady’s demise from metastatic breast cancer strikes a poignant note yet again on the complex challenges which interact with ... Malaysia Kini,
Therapy Targets Brain Tumors -- Nov 10, 2005
...effects. Doctors have found a way to personalize cancer therapy for patients with a type of brain tumor called glioblastoma. The ... CIO Today,
Therapy targets brain tumors -- Nov 9, 2005
By Liz Szabo, USA TODAY. Doctors have found a way to personalize cancer therapy for patients with a type of brain tumor called glioblastoma. ... USA Today
Amgen: Cancer Therapy Slows Tumor Growth -- Nov 3, 2005
...said Thursday that its experimental colon cancer therapy, a potential rival to ImClone Inc.'s Erbitux, significantly slowed tumor growth in a late-stage study. ... MSN Money
Cancer patients get new drug before appraisal -- Nov 11, 2005
Roger Owen, a consultant haematologist in Leeds, said: "It is extremely good news that this effective cancer therapy is now available to patients in this area ... Yorkshire Post Today,
Research finds drug prolongs lives of those with pancreatic cancer -- Nov 12, 2005
...increasing survival from six months. "This is a small improvement, but that's what we do in cancer therapy. We take one step at ... Houston Chronicle,
Introgen's INGN 241 Works Synergistically With Celebrex(R) to Kill ... -- Nov 8, 2005
...and the favorable safety profile of INGN 241 observed in clinical trials to date support additional study of this regimen as a novel breast cancer therapy. ... PR Newswire (press release),
Doctors hail new cancer therapy -- Oct 19, 2005
By Jeff Donn. A drug that targets only diseased cells has proved effective against an aggressive form of early breast cancer -- a ... commercialappeal.com (subscription),
Novel Mechanism of Introgen's INGN 241 Cancer Therapy Inhibits ... -- Oct 29, 2005
AUSTIN, Texas, Oct. 28 /PRNewswire-FirstCall/ -- Introgen Therapeutics, Inc. (NASDAQ:INGN) today reported data describing a novel ... Biotech Intelligence (press release),
Novel Mechanism of Introgen's INGN 241 Cancer Therapy Inhibits ... -- Oct 28, 2005
AUSTIN, Texas, Oct. 28 /PRNewswire-FirstCall/ -- Introgen Therapeutics, Inc. (Nasdaq: INGN - News) today reported data describing ... Yahoo! News (press release)
Novel Mechanism of Introgen's INGN 241 Cancer Therapy Inhibits ... -- Oct 28, 2005
AUSTIN, Texas, October 28, 2005 /PRNewswire-FirstCall/ -- Introgen Therapeutics, Inc. today reported data describing a novel mechanism ... PharmaLive.com (press release),
Sniper treatment spells significant breakthrough in approach to ... -- Oct 26, 2005
Scientists at the University of Dundee have demonstrated that cancer cells can be targeted and destroyed by a single blast of ultrasound according to an ... Scottish Enterprise,
Mice Provide Insight Into Therapy-induced Cancers In Humans -- Oct 20, 2005
...led by the Melbourne Branch of the Ludwig Institute for Cancer Research (LICR) has identified a potential new target for stomach cancer therapy, according to a ... Science Daily (press release)
Distinguished Oncology Researcher, Dr. Robert Kerbel, Discusses ... -- Nov 10, 2005
...agent would prevent the onset of neovascularization, or regrowth of blood vessels that enable a tumor to survive and proliferate after cancer therapy, from the ... Gen |
